Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of ARS Pharmaceuticals Inc (NASDAQ: SPRY) was $14.88 for the day, up 2.98% from the previous closing price of $14.45. In other words, the price has increased by $2.98 from its previous closing price. On the day, 1.42 million shares were traded. SPRY stock price reached its highest trading level at $15.13 during the session, while it also had its lowest trading level at $14.3983.
Ratios:
Our analysis of SPRY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 06 ’25 when Shawver Laura sold 50,000 shares for $11.10 per share. The transaction valued at 555,065 led to the insider holds 210,346 shares of the business.
Shawver Laura bought 50,000 shares of SPRY for $555,065 on Jan 06 ’25. On Dec 17 ’24, another insider, Tanimoto Sarina, who serves as the CHIEF MEDICAL OFFICER of the company, sold 100,000 shares for $11.67 each. As a result, the insider received 1,167,100 and left with 1,098,499 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1446120320 and an Enterprise Value of 1239319040. For the stock, the TTM Price-to-Sale (P/S) ratio is 562.69 while its Price-to-Book (P/B) ratio in mrq is 7.19. Its current Enterprise Value per Revenue stands at 482.601 whereas that against EBITDA is -20.504.
Stock Price History:
The Beta on a monthly basis for SPRY is 0.99, which has changed by 1.3268921 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $6.13. The 50-Day Moving Average of the stock is 17.39%, while the 200-Day Moving Average is calculated to be 26.57%.
Shares Statistics:
SPRY traded an average of 1.30M shares per day over the past three months and 1542480 shares per day over the past ten days. A total of 97.15M shares are outstanding, with a floating share count of 51.12M. Insiders hold about 47.40% of the company’s shares, while institutions hold 42.21% stake in the company. Shares short for SPRY as of 1736899200 were 14810932 with a Short Ratio of 11.41, compared to 1734048000 on 12656935. Therefore, it implies a Short% of Shares Outstanding of 14810932 and a Short% of Float of 28.65.
